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Comorbidity is an increasingly important term describing the health status in an aging 
population worldwide. Writing on comorbidity in a population living in the context of Finnmark 
with its geography, socioeconomic traits, history and culture, has been intriguing.  
I have a firm belief in the importance of equal possibilities to healthy life choices. Through this 
work, the possibility of pointing out some areas of potential or concern has been a huge 
motivator. We have a national and public health care system in Norway, but Norwegian lives 
are highly local. Our efforts in structuring our health sector should be adjusted thereafter.  
The following master thesis in MED-3950 was a project first formed by dr. Jan Norum. He was 
an oncologist situated both in the Hospital Trust of Finnmark, Hammerfest, and at the 
University Hospital in Tromsø.  
Sadly, dr. Norum passed away in March 2019. It has been my goal to finish this project as 
planned. In April, I was pleased to have dr. Eyvind J. Paulssen, professor II at the Department 
of Clinical Medicine, UiT The Arctic University of Norway, agree to help me finish the project 
with academic guidance and statistical expertise. Also, Dr. Uwe Ugledahl, chief surgeon in the 











































List of Tables 
 
Table 1: Cause of death in Finnmark County .......................................................................... 23	
Table 2: Level of education in Finnmark County .................................................................... 24	
Table 3: Level of unemployment in Finnmark County ........................................................... 24	
Table 4: Calculation of the Charlson Comorbidity Index (CCI) ............................................. 25	
Table 5: Baseline characteristics of the study population ........................................................ 26	
Table 6: Length of hospital stay at the Department of Surgery, Hammerfest hospital ........... 27	
Table 7: Comorbidity burden in the study population ............................................................. 28	
Table 8: Geographical distribution and estimated travel distance to hospital. ........................ 29	
Table 9: Univariate logistic regression analysis ...................................................................... 30	
Table 10: Multivariate logistic regression analysis ................................................................. 31	
 
List of Figures 
Figure 1: Model of research hypothesis H1. ............................................................................. 32	







BMI  Body Mass Index = kg/m2 
CCI  Charlson Comorbidiy Index 
CKD  Chronic kidney disease 
CHF  Congestive heart failure 
COPD  Chronic obstructive pulmonary disease 
LEL  Low educational level 
LOS  Length of stay 
HEL  High educational level 
MI  Myocardial infarction 
MM  Multimorbidity 
PRI  Patient registry index 
PUD  Peptic ulcer disease 
PVD  Peripheral vascular disease 
QoL  Quality of Life 







Background: The citizens of Finnmark have higher mortality than Norway at large. 
Comorbidity can today be measured using methods like the Charlson Comorbidity Index (CCI). 
Comorbidity and the burden of smoking, measured in pack years, amongst patients admitted to 
Finnmark Hospital Trust have never been investigated. Knowledge of these variables can 
presumably lead to better patient treatment and follow up.  
Objective: Measuring CCI, BMI and pack years in patients admitted to the Department of 
Surgery at Hammerfest Hospital in the Finnmark Hospital Trust. I wanted to investigate how 
these exposure variables impact on length of hospitalisation, measured by hospital stay >4 days.  
Method: All patients admitted to the Department of Surgery between 18 November and 10 
December 2018 were registered. Reading records one year prior to admission, I recorded all 
CCI-diagnoses and calculated individual comorbidity scores. Age, length of hospital stay, and 
smoking status was recorded. Pack years and BMI were calculated. Logistic regression analysis 
was used to evaluate the exposure impact on the outcome. 
Result: Eighty patients were included in the analysis, of which 66.2% were men. Half of the 
patients were >70 years of age. Twenty-seven (32%) had >4 days of hospital stay. The mean 
CCI score was 5.20 (range 0- 13, SD 3.6). One unit increase in CCI score increased the risk of 
the outcome by 19% (OR 1.19, 95% CI 1.04-1.37). This effect disappeared in the multivariate 
logistic regression.  
Conclusion: None of the examined variables displayed a significant effect on the length of the 
hospital admission in this study. The study is the first of its kind in Finnmark. Due to low 
internal validity the results should be interpreted with caution. Further research is needed to 




1 Introduction   
 
There is a high prevalence of cardiovascular disease and diabetes in Finnmark (1-3). The 
prevalence of diabetes was highest amongst men and increasing with body mass index (BMI) 
(4). Compared to the rest of the country (hereafter: Norway) life expectancy in Finnmark 
County is low. For men, life expectancy has been reported to be 2-3 years shorter than in 
Norway. For men and women born 2011-2015, the life expectancy is 77.2 and 82.3 years, 
compared to 79.7 and 83.7 years in Norway (5, 6). According to the Norwegian Cause of 
Death Registry, more people die of cardiovascular disease, cancer, lung disease, and serious 
trauma in Finnmark than in Norway when applying standardized rates pr. 100 000 (Table 1).  
 
There are both medical and economical arguments for awareness of multimorbidity (MM) 
within a population (7-9). In Denmark, the proportion of patients followed in multiple clinics 
simultaneously nearly doubled over a 10-year period (10). An increase in MM does not fit 
well with silo-based models of patient care with single-disease frameworks for patient follow-
up, and poses a challenge to health care systems worldwide (11). Better understanding of the 
epidemiology of MM is necessary to develop adequate interventions to prevent it, reduce its 
burden and align health-care services closer to the patients’ needs (12). Coaching given to the 
chronically ill elders and their caregivers to ensure that their needs are met during care 
transitions may reduce the rates of subsequent re-hospitalization (13). It is strongly suggested 
that low educational level (LEL) is associated with higher overall and premature mortality 
and that the association is affected by MM, lifestyle factors, and quality of life (QoL). This 
should be taken into account when treating people with MM in order to reduce the 
socioeconomic inequalities in mortality (14).  
In Norway, an analysis of the geographical differences in mortality showed that level of 
education, income, and other sociodemographic factors could explain 70-80 percent of the 
geographical variation in mortality (15). This strongly suggests that MM-awareness and 
demographic variables in different regions of a country should be considered when structuring 
the health care facilities. The risk of medical errors during transition in care for patients with 
MM can be high (16), and furthers the argument of keeping track of patient comorbidity 
status in a health infrastructure so dependent on cooperation between primary and secondary 





Finnmark is the northernmost county in Norway. Finnmark Hospital Trust has two hospitals,  
situated in Hammerfest (west) and Kirkenes (east), two cities 492 km apart by road. Many 
patients live in rural areas. Finnmark has the longest transition time in Norway to inpatient 
clinic hospital care during the event of acute illness: 3 hours and 46 minutes on average for 
the 90 percentile (17). Patients, in general, do not live close to their hospital and are under the 
primary care of the local municipalities. There are 19 municipalities in Finnmark, of which 10 
have Hammerfest Hospital as their local hospital in western Finnmark. In Finnmark, as in the 
rest of the country, fewer people smoke now than before. Still, people here smoke more than 
the average Norwegian (18). Also, the trend for using other tobacco products (“snus”) is 
increasing. The people of Finnmark consume more medications than the rest of the country 
(19). Compared to the neighboring county of Troms and the country at large, Finnmark also 
has the lowest level of education (Table 2) and the highest degree of unemployment (Table 3).   
1.1.2 Pack years 
The prevalence of COPD and the incidence of lung cancer in Finnmark is the highest in 
Norway (20). Smoking is a known contributor to the burden of morbidity and death (21), and 
smoking cessation has proven useful to reduce mortality (22). Use of tobacco has potential 
adverse effects on surgery and perioperative complications and encouraged smoking cessation 
in a surgical setting is beneficial to the outcome (23-25). In non-cardiac surgical patients, 
smoking is associated with a 40 percent increase odds of 30-day mortality and a 30-100 
percent increase odds of major morbidity, including surgical site infection, pneumonia, 
unplanned intubation, and septic shock (25). Making an effort to inform patients of the risks 
of smoking before being admitted to elective surgery improve perioperative results (26).   
From the socioeconomic point of view, the trait of educational levels and its association with 
smoking habits is assumed to be one of the most important causes of social inequalities in life 
expectancy (27). It is shown in Norway that different smoking habits and subsequently 
differences in mortality due to smoke related diseases is an important cause of death, and 
further more that smoking is correlated with lower educational background (28).  
We can note that in general: Smokers tend to have lower education levels than non-smokers; 
people with lower educational levels tend to be more multimorbid; and multimorbid patients 
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tend to have more risk factors for chronic diseases than others. In summary, smoking is 
strongly correlated to socioeconomic factors (29).  
1.1.3 Comorbidity  
Comorbidity is defined as having chronic conditions in addition to the main diagnosis of 
concern. I.e. the total and current disease burden in addition to “disease A”. Multimorbidity 
(MM) is defined as living with two or more chronic conditions at the same time (30). That is 
living with “disease A” and “disease B”, or more. The two terms are often intertwined, and 
the measurement of MM in a population is not yet standardized due to a great variety of 
methods and definitions (30-32). In this report, comorbidity is regarded as a measurable size 
describing concurrent disease when viewing a patient with a certain “disease A” presenting in 
the clinical setting. Comorbidity is measured using the Charlson comorbidity index (CCI) (33, 
34). MM is viewed as a more descriptive variable, useful in population studies to evaluate the 
prevalence of multiple morbidities within the population.  
Regarding MM, there is a relationship between smoking habits and the CCI score. In a study 
on acute coronary syndrome patients, the baseline characteristics differed significantly 
between the CCI=0 and the CCI≥3 group, particularly when considering risk factors such as 
hypertension, dyslipidemia and obesity (35). Additionally, the study found the proportion of 








Rural populations have lower life expectancy, lower education levels, and a higher burden of 
smoking with all its adverse effects. As described above, the burden of comorbidity is higher 
in populations with these traits. Considering poorer public health status in Finnmark, it could 
be assumed that patients admitted to a surgical ward in Finnmark would have notable higher 
comorbidity at admittance. 
Comorbidity at hospitalization in Finnmark hospital trust has never been measured. There are 
tools available for this (34, 36). CCI is one of the most used and validated tools to increase 
the representability of comorbidity in longitudinal studies (33-35), and the index is also 
validated for the Norwegian setting (34).  
The main aim of this study was to investigate the comorbidity amongst patients admitted to 
the Department of Surgery at Hammerfest hospital using CCI. We wanted to compare it to the 
calculated Norwegian mean value of CCI (34). The secondary aim was to obtain information 
on the patients’ burden of tobacco smoking and BMI, and impact on comorbidity and hospital 
length of stay (LOS). In this thesis, LOS is an outcome of interest, and we understand LOS as 
a proxy for health care consequences of MM.  
As such, our research hypothesis (H1) is that “length of hospital stay” is affected by “burden 
of comorbidity”, and furthermore that “BMI” and ”tobacco smoking” have an impact on this 
outcome. The null hypothesis to be statistically tested is that there is no correlation as 




3 Material and methods 
 
3.1 Material 
3.1.1 Study population 
We registered prospectively, between 18 November 2018 and 10 December 2018, 
continuously every person hospitalized at the Department of Surgery at Hammerfest hospital 
(n=105). Registered patients with lack of data (n=14), family or friends hospitalized together 
with the patient (n=5), and citizens outside Finnmark (n=2) were excluded from the study 
(total n=25). A total of N=80 patients were submitted to analysis in the study. The screening, 
exclusion, and inclusion of patients are shown in Figure 2. 
3.1.2 Variables of interest 
The following data were obtained from the electronic patient record (EPR, named DIPS®): 
Variables registered directly from DIPS: Age, sex, municipality, tentative diagnosis at 
hospitalization, state of emergency (elective or acute), final diagnosis. Calculated variables: 
BMI, CCI-score and hospital stay. We also registered the burden of tobacco smoking in terms 
of pack years, calculated using an online calculator (37).  
3.1.3 Comorbidity index 
The comorbidity score was calculated employing the CCI calculator provided by MDCalc 
online (38). We registered all comorbid conditions registered in the patient journal 12 months 
before the index date of admittance, as done by Nilssen et al. (34). Also, it was noted if 
patients died within four months following the index date. The CCI diseases of interest were 
recorded with weighted points in accordance with the online CCI calculator and original 
methods (33). The different score points of 1, 2, 3 and 6 were added used to calculate the CCI 
index score, making it an index reaching from min = 0 to max = 33 points. An overview of 
the points given to calculate the index is found in Table 4. 
Also, age is weighed in with each decade >50 and up to >80 years of age adding 1 point on 




3.2 Statistical analysis, approvals, and ethics 
3.2.1 Ethics 
The study was performed as a quality of care project. Consequently, no approval from the 
Regional Committee for Medical and Health Research Ethics (REK) was necessary. The 
project was approved by the Data protection officer at the Finnmark hospital trust. 
Microsoft Excel was used for the database and some statistical calculations. Each patient was 
given a code number, and the key to the codes was kept separate in a locked draw. 
Descriptive statistics were performed employing SPSS version 24.  
3.2.2 Descriptive statistics  
Baseline characteristics for the study population are shown in Table 5. Additionally, hospital 
stay, CCI disease frequency, and geographical distribution of patient home municipalities is 
presented in three explanatory tables (Table 6-8). 
3.2.3 Logistic regression analysis 
For the logistical regression analysis performed in SPSS, the following considerations were 
made in plotting the different variables of interest. To avoid possible confounders on length of 
hospital stay, we dichotomized the variable and defined >4 days as “long hospital stay”. 
Choosing the mean length of stay has been the rationale in other studies investigating 
variables predicting hospital stay (39). The median length of stay in our population was 3 
days, and the mode was 1 days (Table 6). We chose >4 days, as this represented 1/3rd of the 
study population, and to adjust for those with longer stay due to weekends other external 
factors (i.e. weather conditions, transportation, primary health care capacity).  
We grouped the CCI into four groups: 0 = no comorbidities, 1-2 = low comorbidity burden, 3-
4 = moderate comorbidity burden, and ³5 as high burden of comorbidity, finding descriptive 
statistics / frequencies of the different groups. Charlson et al. (33) employ a similar grouping 
in a previous study. From CCI, we also calculated a variable that presented the comorbidity 
score, excluding the weighed effect of age, to be used in the logistic regression analysis, as 
age was entered as a separate parameter. 
Smoking status was subdivided in 0=non-smoker, 1=smoker, 2=former smoker, 3=no 
information. For the statistical analysis, group 1 and 2 were regarded separately and as one, 
 
 7 
considering the current burden of tobacco vs. life burden of tobacco. The variable of BMI was 
made binary, and as a simplification >25 was considered overweight.  
Using univariate logistic regression analysis, we evaluated the impact from the covariates on 
the dependent variable, hospital stay >4 days. Binary exposure variables were sex (m=0, f=1), 
smoking status (current / not smoking), smoking status (ever / never), BMI >25 (yes, no). 
Continuous variables were pack years, CCI score, and CCI score minus age, and age. Age 
was also grouped in <50, 50-59, 60-69, 70-79, ≥ 80 years. CCI was grouped as explained 
above. The confidence interval was set to 95%. Using multivariate logistical regression 
analysis, we evaluated the combined implication on hospital stay of the exposure variables in 
the univariate logistic regression analysis that had a p-value <0.25, to allow for all exposure 






4.1 Patient characteristics  
Patient characteristics are shown in the tables section (Table 5 and 6). Most patients were men 
(57.5%); most were in their 8th decade of life (32.5%); most had a previous or current history 
of smoking (72.2%); over 50% of the population was over 70 years of age at admittance. 1/4th 
of the population had only one day long hospital stay, and 56% had 1-3 days of hospital stay. 
Most of the patients stayed <4 days in hospital (66.2%). 
4.2 Comorbidity burden 
There was a total of 139 comorbid CCI-diseases registered, giving an average of 1.74 
comorbidities per patient (Table 7). The top five CCI diseases in the study population were: 
Solid tumor (14%), chronic obstructive pulmonary disease (COPD) (12%), cerebrovascular 
disease (CVD) (11%), metastasis from cancer (9%) and MI (9%). Mean 10-year calculated 
survival rate in our study population was 0.40. In the four months following index date, a total 
of 11 patients passed away, making it 13.75% of the study population (n=80). Mean 
calculated CCI score was 5.20 (range 0-13, SD 3.6).  
4.3 BMI, pack years and travel distance 
The mean BMI in the study population was 25.8 (range 17-40, SD 4.7). The mean burden of 
pack years was 22.48 (range 0-212, SD 34.0).  
Patients in the study sample came from 15 of the 19 municipalities in Finnmark County 
(Table 8). The five most prevalent patient municipalities were Alta (25%), Hammerfest 
(16%), Karasjok (14%), Porsanger (13%) and Måsøy (6%). 9% of the patients came from 
municipalities primarily bound to Kirkenes hospital in the eastern part of the Finnmark 
hospital trust. Calculating the average estimated travel distance per patient one way to 
Hammerfest hospital, the average distance was 156.55 km and required an estimated 2.6 
hours of travelling time at 60 km/h average travel speed. 
4.4 Univariate analysis 
We found the exposure of age to increase the risk of hospital stay >4 days by 5% per year 
increase in age (95%CI 1.01-1.09), as shown in Table 9. Only age ³80 had a significant 
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impact on the risk of hospital stay >4 days in the grouped age categories (OR 6.00, 95%CI 
1.00-35.81). The increase in one unit CCI score increased the risk of the outcome by 19.4 % 
(95%CI 1.04-1.37). For the age-adjusted CCI score, the risk of outcome was 24.4% per 
increased score unit (1.04-1.50), with the score group ³5 the significant of the grouped scores 
(OR 8.73 95% CI 1.62-46.94). For the age groups 50-59, 60-69, 70-79, smoking status, and 
BMI>25, there were no significant findings.  
 
4.5 Multivariate analysis 
None of the exposure variables that were significant in the univariate analysis had a 
significant impact on risk of hospital stay > 4 days when adjusted for each other, as shown in 
Table 10. CCI-score, age, sex, or smoker status had no significant impact on the risk of 







5.1 Discussion of findings 
In the univariate logistic regression analysis an increase in age and CCI predicted increased 
risk of hospital stay > 4 days. When performing the multivariate analysis, this effect was 
eliminated. Neither CCI, nor age, sex, or smoker status, had a significant impact on the risk of 
prolonged hospital stay. Compared to findings in other studies (40-42), these results are 
unexpected.  
5.1.1 Comorbidity in the study population 
Nilssen et al. (34) created a patient register index (PRI) in Norway based on the CCI. Their 
calculated mean CCI was 0.43. In our study sample, the mean CCI and mean age-adjusted 
CCI was 5.20 and 2.95, respectively.  The higher mean values in our analysis may be 
explained by the baseline differences in our sample populations. Their large sample 
constituted the entire Norwegian patient registry, and our much smaller sample was drawn 
from a selected group of patients admitted to the Department of Surgery in Hammerfest. 
Considering the study by Nilssen and co-workers more in detail, some baseline characteristics 
separated our study samples from theirs: First, their study sample was extracted from the 
Norwegian patient registry, with all age groups from zero up included – whereas over 50% of 
our patients were over 70 years of age. The majority (57%) in the PRI-study were female, we 
had the direct opposite distribution. 68% of the index visits were at hospitalization (in-
patient), we had 100% of our patients registered at hospital admission to the Department of 
Surgery. Twenty-two % of the PRI-patients were registered with at least one CCI disease, 
compared to 77.7% in our population. However, one important similarity can be found: 
increasing age is related to increase in CCI.   
Regarding the mean CCI in presumably more comparable populations prone to surgery, 
different studies report a mean CCI in their sample of 2.21 (40) and 2.90 (43) – more similar 
to our findings. However, these cannot put in direct comparison to our results due to our 
limited validity, as discussed in section 5.2.1 below.  
In the PRI-study by Nilssen et al., the top five diseases were chronic pulmonary disease 
(4.9%), MI (4.0%), any malignancy (3.8%), CVD (3.8%) and CHF (2.9%). In the AMIS 
study (35) from Switzerland, top five were MI (18.0%), Diabetes without chronic 
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complications (14.7%), renal disease (7.1%), CVD (6.0%) and chronic lung disease (6.0%). 
Bear in mind that the AMIS study patients were admitted with acute coronary syndrome, and 
arguably the population could be expected to be more prone to cardiovascular disease and 
lifestyle disease burden. 4/5 and 3/5 of the equivalent CCI-diseases in our study sample 
(Table 7) were in the top five for the studies mentioned above. 
In the literature, several studies point out the predictor impact of CCI on length of stay (LOS), 
though it is hard to find sample populations directly comparable to ours: In a study assessing 
LOS following robot-assisted prostatectomy, CCI was the only independent predictor (41). 
The CCI score has been associated with length of stay and hospital costs incurred following 
treatment for hip fracture (42). Among older adults hospitalized for acute stroke, higher 
global comorbidity (CCI ≥ 2) was associated with adverse clinical outcomes, and thereby 
LOS (40). Yet another study considered the utility of CCI as a predictor of LOS for lower 
extremity injury patients (44). In our report, it is hard to argue for any strong impact of CCI 
on LOS due to low internal validity. However, our findings do point in that direction, as 
concluded in the multivariate analysis.  
5.1.2 The impact of smoking and BMI 
The secondary aim of our study was to reveal the patients’ burden of tobacco smoking and 
BMI and these two variables impact on comorbidity and hospital stay. In the univariate 
logistical regression analysis, we found no significant impact of increased BMI >25 on length 
of stay. This variable is inadequate in several ways. The mean BMI in our population was 
25.8 (Table 5) and as discussed below the certainty of the measures at admittance are unclear. 
In retrospect, the cut-off value of BMI >25 could have been been increased. It might have 
given a different result in analysis if i.e. BMI >30 was the variable describing of overweight. 
Presumably, it should also be considered if high age and MM incurs a high BMI, or if this 
patient group has a lower BMI than average. It is beyond the scope of this report to further 
discuss these potential confounders.  
Though our results did not show any significant effect of pack years on outcome, it should be 
noted that 72% of our patients have a history of smoking.  For reasons discussed in the 
following sections, the lack of significant results in the analysis does not rule out that a 
history of smoking has an impact on length of hospital stay in Finnmark. As shown in the 
introduction, the literature is clear on the fact that efforts to encourage and facilitate smoke 




5.2.1 Internal validity 
The present study employ a univariate and multivariate logistic regression to assess the 
impact of CCI and the other exposure variables on the binary outcome “hospital stay > 4 
days” (yes/no). The multivariate logistic regression analysis allows us to control for different 
confounding effects. In the following discussion on validity, bias and reliability are 
considered (45, 46). 
Selection bias 
All admittances to the Department of Surgery at Hammerfest Hospital in the data collection 
period were registered. As delineated in the flow chart (Figure 2), certain patients were 
excluded to avoid the risk of selection bias (i.e., patients not from Finnmark or family of 
admitted patients). The data collection time is set in November and December, a tough and 
dark period in the arctic region. This has potential consequences for road traffic and the 
availability of flights to, from, and within in Finnmark. If this affects patients’ willingness to 
travel the distance for elective surgery, or the possibility of going to Hammerfest (not 
Kirkenes or Tromsø) in an acute setting, it could be argued that this may give grounds for 
sampling error (45). 
Information bias 
Measurement errors or observational errors can lead to information bias. The risk of 
information bias is present regarding several of the variables included in the analysis. The 
outcome variable “hospital stay” was recorded by subtracting the time of admittance to the 
department from the time of exit. In the cases where patients were re-admitted (less than one 
week later for the same condition, or were readmitted less than one week later during an 
“open return”) for the same condition, the total time of in-hospital stay was summarized. The 
same strategy was applied for the patients transferred between hospitals 
(Hammerfest/Kirkenes/Tromsø), or between departments within Hammerfest Hospital. 
Similar considerations were made for “same condition admittance” before the index date.  
This strategy is prone to information bias due to an unclear definition of terms, and risk of 
measurement error in the process of recording the data. First, it can be asked if the 
transmissions and admittances were correctly dated and recorded. Second, if these pieces of 
information were correctly collected when going through the journals. Last, the limits of “one 
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week” was an arbitrary choice, and may itself be a measurement error. As explained above 
under methods and statistics, section 3.2.3, this kind of bias and the many possible 
confounding effects interplaying with the length of stay was attempted corrected for by 
dichotomizing the outcome variable, and performing a multivariate logistic regression 
analysis. In future studies, a different approach to investigating the dependent variable “length 
of hospital stay” could be interesting. 
Regarding the exposure variables, i.e. the calculated variable of pack years, there are several 
steps of information from the “truth” to what is written in the patient records. In this study, 
there is also a risk of making mistakes when going through the records in hindsight, and when 
calculating the actual pack years. Similar risk of bias due to measurement error could be 
expected in the records of BMI and disease history, where there is a risk of information bias 
due to, i.e. patient recollection. In addition, factors such as smoking status and weight (unless 
measured) can be vulnerable to an interview effect, leading to measurement bias due to lack 
of desire to admit to socially disliked habits or traits.  
During the review of journals in DIPS, it was notable that some central information was 
copied from previous journals, (i.e., information on disease history or the use of stimulants). 
This copy-paste solution is understandable; however, it begs the question if nuances or key 
information might get lost on the way. This could lead to information bias due to an implied 
“yes-effect” from the fact that it is assumed the patient has remained status quo since previous 
admittance. 
Medical history records are vulnerable to information bias due to the limited patient 
recollection of personal medical history. The 17 different diagnoses were recorded in 
accordance with the limitations noted on the MDCalc website. During the recording of data 
from DIPS, a few uncertainties in diagnosis definition exist as a potential source of 
information bias. The following, MI, PUD and CKD, left some operational decisions that may 
be biased. Regarding any history of MI, it was noted in some journals both coronary bypass 
surgery and PCI treatment. Though presumably due to chronic occlusion, and not ACS, this 
leaves some uncertainty. These patients were not recorded as have history of MI, though it is 
unclear if that was the case. Regarding PUD, many patients received different proton pump 
inhibitor (PPI) medicaments, but only those who had a definite description of visually 
confirmed ulcerative disease in the upper GI was recorded. Though many patients had a note 
of “kidney failure” at different levels in their journals, the MDCalc has a limit for moderate 
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chronic kidney disease (CKD) only to be noted when creatinine >3 mg/dl (0.27 mmol/L). In 
DIPS’ creatinine is measured in µmol/L, making the limit 270 µmol/L. None of our patients 
had creatinine levels this high at admittance, but due to history recording of severe renal 
disease, three patients were given this CCI diagnosis.  
Bias in analysis 
The risk of finding associations by chance is present in all research. To avoid the error of 
reporting a difference which is not real (a type 1 statistical error), we applied a level of 
significance of α=0.05, meaning that a p-value of <0.05 leads to a rejection of the null 
hypothesis (H0).  However, the risk is still that 1/20 samples from a population where the null 
hypothesis is true, the p-value will be <0.05. So, even though we have a significant finding in 
our study, there is still a 5% chance of type 1 error rejecting H0. (46)  
For a statistical test result; the larger the sample size, the narrower the CI, the larger the test 
statistics, and the smaller the p-value. In our case, the sample is >60, making it arguably large 
enough to calculate a CI regardless of the normal distribution in our sample. Yet N=80 leaves 
some limitations. For our significant results in the univariate analysis (Table 9), the 
confidence intervals were large. E.g.for the significant finding on age-adjusted CCI, OR was 
1.244, and the 95% CI was 1.035-1.496. Interpreting this means that the true risk of entering 
the outcome category for one unit comorbidity index score increase would be somewhere 
between 3.5% and 49.6%. Our relatively small sample size also leaves us at risk of not giving 
value to what could have been important differences; that is, keeping the null hypothesis and 
rejecting that some of our exposure variables had a true impact on hospital stay >4 days. 
Furthermore, in our attempts to stratify the population into CCI categories and age groups, the 
risk of type 2 error is highly present, and our non-results should also be viewed with caution.  
5.2.2 External validity 
External validity is expected to be low, given the low internal validity.  Already by choosing 
our study population from a Department of Surgery, the external validity of our potential 
findings is expected to be limited. It is not likely our findings can be generalized to all 
surgical patients admitted to Hammerfest Hospital, making it hard to argue for any external 
validity to comparable hospitals in other regions. This problem is exemplified above in 
section 5.1.1 when comparing the CCI in our study with the CCI found from the Norwegian 
patient registry study of Nilssen et al. (34).  In summary, internal validity, and thereby also 
external validity, is not satisfactory in this study. 
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5.2.3 Other possible confounders 
Age and CCI-score are known predictors to evaluate the risk of death from a comorbid 
disease. Populations more prone to having multiple morbidities have some common traits; as 
Lund Jensen et al. (14) have shown, MM is more prevalent among people of lower 
socioeconomic status (SES), and both MM and SES are associated with higher mortality 
rates. The study concluded that LEL is associated with a higher overall and premature 
mortality and that the association is affected by MM, lifestyle factors and QoL. As noted in 
the introduction, Finnmark at large pertains several of the risk factors having an impact on the 
increased burden of mortality and morbidity. This report does not further evaluate 
confounders related to the observed higher mortality and morbidity in Finnmark.  
Alcohol consumption was noted, and 13 patients had a journal at admission describing the 
prior or current problem of exceedingly high alcohol consumption. Though this trait accounts 
for 16.5% of our study population, it is not a result our study design was planned to include, 
and the investigation is here regarded as interesting for a descriptive purpose. Mean 10-year 
calculated survival rate in our study population is 0.407, meaning an expected survival of 
only 4 out of 10 patients after ten years from admittance. This may not be so unexpected, 
considering >50% of the patients are older than 70 years at admittance. However, it is beyond 
the scope of this thesis to further investigate this variable. Also, 11 patients were recorded 
dead in DIPS within four months from the index date. Other and much larger studies doing 
similar validating of CCI, use one-year follow up or death within that time from index date as 
the end of follow up (34). Given the size of the sample, the limitation of follow up time, and 
the limited evaluation of the cause of death, this is not added to our analysis.  
In Table 8 we show the estimated travel distance and “time in transit” for the patients in our 
sample. Though our estimate of 2,6 hours travel time is lower than the estimate presented in 
the introduction (17), it cannot be regarded as more than a mere curiosity due to differences in 
methods, a small sample size, and considerable approximations in our model. There are many 
other confounders to “time in transit” than “average travel speed” alone. However, the 
calculations on “time in transit” are included in Table 8 and presented here as a reminder on 




5.3 Limitations, strengths and implications 
As discussed in the section on material and methodology above, this study encounters many 
limitations. First, the study sample is very limited (n=80). Second, the data collection period 
is short and in a particular time of year– contributing to a small sample size, and to a seasonal 
risk of selection bias. Third, the data set is collected retrospectively from journal notes one 
year prior to the index date of admission, leaving room for the bias of information and human 
subjective error of interpretation in the clinical setting. Assumable, there can also be a 
difference of history depth priority depending on the acuteness of the clinical case in question, 
i.e., differences in accuracy of disease history, the actual weight or smoking status. Lastly, the 
lack of 1 year follow up limits the usability of the results, as we only have 4 months follow up 
time, and limited knowledge of cause of death other than the fact of death in DIPS.   
As a preliminary attempt to record the comorbid status in the population undergoing surgery 
at Hammerfest hospital in Finnmark, to our knowledge this study is the first. We know that 
Finnmark has a higher mortality, a lower educational level, and a higher burden of tobacco 
than Norway at large. The lack of results in this study should encourage rather than 






In this cross-sectional study of comorbidity, the mean Charlson Comorbidity Index (CCI) 
Score is 5.20 (range 0-13, SD 3.64). I found no effect of the CCI-score on length of hospital 
stay. Neither of the controls (age, sex, smoker status, or BMI) had a significant effect either. 
Due to the low internal validity, these results must be interpreted with caution. However, the 
study is the first of its kind in Finnmark Hospital Trust. Further research is needed to properly 
account for the burden of comorbidity in this region. A larger study sample and more 
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7 Figures and tables 
 
Table 1: Cause of death in Finnmark County 
Cause	of	death	Finnmark	county	compared	to	Norway	in	total:	Standardized	ratesa	pr.	
100.000	sorted	by	county	sex	and	cause	of	death.b	
Cause	of	death	 	 County	 Year	
1970	 1990	 2017	
All	 	 Total	 1671	 1428	 893	
	 	 Finnmark	 1937	 1735	 1116	
Death	from	disease	 	 Total	 1588	 1353	 825	
	 	 Finnmark	 1834	 1635	 1028	
	 Malignant	tumors	(cancer)	 Total	 270	 290	 239	
	 	 Finnmark	 274	 304	 288	
	 Cardiovascular	disease	 Total	 881		 680	 229	
	 	 Finnmark	 1065	 892	 300	
	 Disease	in	respiratory	organs	 Total	 188	 157	 103	
	 	 Finnmark	 240	 144	 133	
Injuries/intoxications	 	 Total	 83	 75	 51	








Table 2: Level of education in Finnmark County 
Highest	level	of	educationa	–	proportion	(%),	population	>45	yoa,	both	sexes	


























Table 4: Calculation of the Charlson Comorbidity Index (CCI) 
The	weighed	points	given	to	calculate	the	Charlson	Comorbidity	Index	(CCI)	score	(a,	b)	
Points	 Disease	history	
1	 History of myocardial infarction (MI); heart failure (CHF); peripheral vascular disease 
(PVD); cerebrovascular disease (CVD); dementia (DEM); chronic lung disease (here: 
COPD); connective tissue disease (CTD); peptic ulcer disease (PUD); mild liver disease 
(LD) and diabetes (DM).	
2	 Diabetes with target organ damage (DM+), hemiplegia (HP), moderate to severe renal 
disease (CRD), malignant neoplasm (solid tumour), leukaemia (LEUK), and lymphoma 
(LYMPH).	
3	 Moderate to severe liver disease (LD+).	









Table 5: Baseline characteristics of the study population 
Baseline	characteristics	of	the	study	population	
	 	 Descriptive	statistics	
	 N	(%)	 Mean	(range)	 SD	
All	patients	 80	(100)	
Sex	 	 	 	
Female	 34	(42.5)	 	 	
Male	 46	(57.5)	 	 	
Age		 	 65.57	(19	–	91.4)	 17.52	
<50	 14(17.5)	 	 	
50-59	 10	(12.5)	 	 	
60-69	 14	(17.5)	 	 	
70-79	 26	(32.5)	 	 	
³80	 16	(20.0)	 	 	
Hospital	stay	 	 7.93	(0	–	166)	a	 20.02	
>	4	days	 27	(33.8)	 	 	
Smoking		 79	(98.8)	 	 	
Current	smoker	 26	(32.9)	 	 	
Ever	smoked	 57	(72.2)	 	 	
Pack	years	 	 22.48	(0	–	212)	 33.99	
BMI	 	 25.80	(17	–	40)	 4.70	
Creatinine	(µmol/L)	 	 77.56	(26	–	241)	 	
10-year	est	survival	rate	 	 0.407b	 	
CCI	score	 	 5.20	(0	-	13)	 3.64	



































































































Total	 80	(100)	 Distance	for	one		 Total	distance	
Alta	 20	(25)	 141	 2820	
Hammerfest	 13	(16)	 2.4	 31,2	
Sør-Varanger	 2	(3)	 482	 964	
Vadsø	 2	(3)	 464	 928	
Porsanger	 10	(13)	 143	 1430	
Nordkapp	 3	(4)	 181	 543	
Kautokeino	 4	(5)	 268	 1072	
Tana	 0	(0)	 353	 0	
Karasjok	 11	(14)	 217	 2387	
Båtsfjord	 0	(0)	 459	 0	
Vardø	 1	(1)	 494	 494	
Lebesby	 1	(1)	 261	 261	
Måsøy	 5	(6)	 168	 840	
Gamvik	 1	(1)	 368	 368	
Kvalsund	 4	(5)	 32.7	 130.8	
Hasvik	c	 2	(3)	 -	 -	
Berlevåg	 0	(0)	 487	 0	
Nesseby	 0	(0)	 371	 0	























Table 9: Univariate logistic regression analysis 
Univariate	logistic	regression	analysis:	Dependent	variable	=	hospital	stay	>	4	days	(yes/no)	
Variable	 OR	 95%	CI	 p-value	
	 	 Lower	 Upper	
Sex	(female)		 1.415	 0.556	 3.602	 0.467	
Age	(years)	 1.049	 1.011	 1.087	 0.010	
Age	(group)	 	 	 	 	
<50	 -	 -	 -	 Reference	
50-59	 0.667	 0.052	 8.549	 0.755	
60-69	 6.000	 0.965	 37.296	 0.055	
70-79	 3.176	 0.580	 17.406	 0.183	
³80	 6.000	 1.003	 35.808	 0.050	
Smoking	 	 	 	 	
Current	smoker		 0.864	 0.315	 2.369	 0.777	
Smoker	(current	or	previous)	 1.983	 0.639	 6.159	 0.236	
BMI	>25	 0.677	 0.256	 1.793	 0.433	
CCI	score	 1.194	 1.039	 1.371	 0.012	
Age-adjusted	CCI		 1.244	 1.035	 1.496	 0.020	
Age-adjusted	CCI	(group)	 	 	 	 	
0	 -	 -	 -	 Reference	
1-2	 4.267	 0.778	 23.404	 0.095	
3-4	 3.636	 0.595	 22.234	 0.162	





Table 10: Multivariate logistic regression analysis 
Multivariate	logistic	regression	analysis:	Dependent	variable	=	hospital	stay	>	4	days	
(yes/no).	
Variable	 OR	 95%	CI	 p-value	
	 	 Lower	 Upper	
Sex	(female)		 1.991	 0.681	 5.825	 0.209	
Age	(years)	 1.044	 0.998	 1.092	 0.062	
Smoker	(current	or	previous)		 1.530	 0.415	 5.638	 0.523	
Age-adjusted	CCI	(grouped	score)	 	 	 	 	
0	 -	 -	 -	 Reference	
1-2	 3.198	 0.503	 20.315	 0.218	
3-4	 1.270	 0.595	 10.256	 0.823	






Figure 1: Model of research hypothesis H1.  
Our research hypothesis is that Charlson Comorbidity Index Score (CCI-score) can 




Figure 2: Flow chart.  
This flow chart shows the exclusions and inclusions made to choose the patients 
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